Keyphrases
Preterm Birth
100%
Interleukin-10
100%
Extracellular Vesicles
100%
Fetal Inflammatory Response
33%
Fetus
33%
Engineered Extracellular Vesicles
33%
Pharmacokinetics-pharmacodynamics (PK-PD)
33%
Maternal-fetal
33%
Organ-on-a-chip
16%
Exosomes
16%
Interventional Strategies
16%
Drugs in Pregnancy
16%
Unanswered Questions
16%
Maternal Cell
16%
Pregnancy Outcome
16%
Yield Data
16%
Non-pregnant Women
16%
Neonatal Outcome
16%
Maternal-fetal Interface
16%
NF-κB Activation
16%
Toxicity Outcomes
16%
Nonhuman Primate Model
16%
Postnatal Complications
16%
LPS-induced Inflammation
16%
Normal Feature
16%
Histologic Chorioamnionitis
16%
Prenatal Complications
16%
Neonatal Death
16%
Induced Preterm Birth
16%
Preclinical Trials
16%
Cytotoxicity
16%
Decidual
16%
Inflammatory Cytokines
16%
Systemic Inflammatory Response
16%
Maternal Inflammation
16%
Animal Testing
16%
Electroporation
16%
Clinical Trials
16%
Immunosuppression
16%
In Vivo Efficacy
16%
Drug Delivery
16%
Cytokine Production
16%
Cargo
16%
Regulatory Agencies
16%
Mouse Model
16%
Humanized
16%
Natural Anti-inflammatory
16%
Modeling Data
16%
Pregnant Mouse Model
16%
Anti-inflammatory Molecules
16%
Global Organizations
16%
Fetal Membranes
16%
Prematurity
16%
Transplacental
16%
In Vitro Model
16%
Maternal Inflammatory Response
16%
Uterine Tissue
16%
Inflammation
16%
Medicine and Dentistry
Premature Labor
100%
Interleukin 10
100%
Serositis
42%
In Vitro
28%
Anti-Inflammatory Drug
28%
Inflammatory Cytokine
14%
Intra-Amniotic Drug Administration
14%
Cytotoxicity
14%
Clinical Trial
14%
Newborn Death
14%
Cytokine Production
14%
Electroporation
14%
Animal Testing
14%
Organ-on-a-Chip
14%
Prematurity
14%
Immunosuppressive Treatment
14%
Fetal Membrane
14%
Reproducibility
14%
In Vitro Production
14%
Chorioamnionitis
14%
Exosome
14%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 10
100%
Premature Labor
100%
Inflammation
71%
Mouse Model
28%
Anti-Inflammatory Drug
28%
Cytokine
14%
Cytotoxicity
14%
Animal Testing
14%
Newborn Death
14%
Prematurity
14%
Chorioamnionitis
14%
Clinical Trial
14%